Digital & Innovation
$19 million investment in Artificial Intelligence medical research

The Morrison Government is investing $19 million in transformative medical research projects using game-changing applied artificial intelligence (AI) technologies, to improve the ways we prevent, diagnose and treat a wide range of health conditions.
The Government is providing more than $8 million for two projects that will use AI to improve mental health treatments for Australians.
The University of Sydney will receive more than $3 million to improve youth mental health care through the development of new tools to guide clinical decisions about the appropriate interventions and treatments for individuals presenting for care.
This project will use AI to test and quantify the impacts of youth mental health interventions and as a result support the development of an ethical clinical decision-support tool that identifies how to target assessment and interventions to optimise outcomes for individuals presenting for mental health care.
The University of New South Wales will receive almost $5 million to use AI to understand and optimise the treatments for stress, anxiety and depression.
AI will be used to understand which interventions, or components of therapies provide the vital, active ingredients, and why they are more effective for some patients and not others.
The aim of this project is to use AI to shorten the trial period where some people are provided with non‑optimal treatments for their conditions and thus improving their health, social and economic wellbeing.
News & Trends - Pharmaceuticals

Government’s long-awaited response to The New Frontier report unveiled after two-year wait
Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]
MoreNews & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’
Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]
MoreNews & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years
Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]
More